Detalhe da pesquisa
1.
Paracaspase MALT1 regulates glioma cell survival by controlling endo-lysosome homeostasis.
EMBO J
; 39(1): e102030, 2020 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31774199
2.
Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial.
Lancet
; 401(10371): 105-117, 2023 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36495879
3.
Endocrine therapy in advanced high-grade ovarian cancer: real-life data from a multicenter study and a review of the literature.
Oncologist
; 2024 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38768082
4.
Clinical impact of CA-125 ELIMination rate constant K (KELIM) on surgical strategy in advanced serous ovarian cancer patients.
Int J Gynecol Cancer
; 34(4): 574-580, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38242546
5.
Survival outcomes of metastatic breast cancer patients by germline BRCA1/2 status in a large multicenter real-world database.
Int J Cancer
; 152(5): 921-931, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36161271
6.
Early Locoregional Breast Surgery and Survival in de novo Metastatic Breast Cancer in the Multicenter National ESME Cohort.
Ann Surg
; 277(1): e153-e161, 2023 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33534229
7.
Hypofractionated Stereotactic Re-irradiation and Anti-PDL1 Durvalumab Combination in Recurrent Glioblastoma: STERIMGLI Phase I Results.
Oncologist
; 28(9): 825-e817, 2023 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37196069
8.
Response to first line platinum-based chemotherapy in mismatch repair deficient (MMRd)/ microsatellite instability high (MSI-high) endometrial carcinoma.
Gynecol Oncol
; 169: 78-84, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36521352
9.
Emotional processes in partners' quality of life at various stages of breast cancer pathway: a longitudinal study.
Qual Life Res
; 32(4): 1085-1094, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36418525
10.
Mammary carcinoma: Comparative oncology between small animals and humans-New therapeutic tools.
Reprod Domest Anim
; 58 Suppl 2: 102-108, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37312625
11.
Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial.
Lancet Oncol
; 23(11): 1367-1377, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36183733
12.
Outcomes of patients with HER2-negative metastatic breast cancer after platinum- and non-platinum-based first-line chemotherapy among patients with and without pathogenic germline BRCA1/2 mutations.
Br J Cancer
; 127(11): 1963-1973, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36207609
13.
Characteristics of Anaplastic Oligodendrogliomas Short-Term Survivors: A POLA Network Study.
Oncologist
; 27(5): 414-423, 2022 05 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35522558
14.
Progression-free survival on endocrine therapy, before or after chemotherapy, in hormone receptor-positive HER2-negative metastatic breast cancer.
Breast Cancer Res Treat
; 191(1): 191-207, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34687411
15.
A phase II study of Navitoclax (ABT-263) as single agent in women heavily pretreated for recurrent epithelial ovarian cancer: The MONAVI - GINECO study.
Gynecol Oncol
; 165(1): 30-39, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35123771
16.
Regorafenib or Tamoxifen for platinum-sensitive recurrent ovarian cancer with rising CA125 and no evidence of clinical or RECIST progression: A GINECO randomized phase II trial (REGOVAR).
Gynecol Oncol
; 164(1): 18-26, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34696892
17.
Adjustment of young women with breast cancer after chemotherapy: A mediation model of emotional competence via emotional distress.
Psychooncology
; 31(5): 848-855, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34989072
18.
Characteristics and outcome of breast cancer-related microangiopathic haemolytic anaemia: a multicentre study.
Breast Cancer Res
; 23(1): 9, 2021 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33468209
19.
Treatment with pembrolizumab in programmed death ligand 1-positive recurrent glioblastoma: Results from the multicohort phase 1 KEYNOTE-028 trial.
Cancer
; 127(10): 1620-1629, 2021 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33496357
20.
The EPICURE study: a pilot prospective cohort study of heterogeneous and massive data integration in metastatic breast cancer patients.
BMC Cancer
; 21(1): 333, 2021 Mar 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-33789635